July 2023
- A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection
Nature, July 19, 2023 - Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo
Cell Reports Medicine, July 17, 2023 - Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy
Nature Communications, July 1, 2023
June 2023
- Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic
JAMA, June 30, 2023 - Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States
NEJM, June 29, 2023 - Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing
The Lancet, June 29, 2023 - An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections
Science Immunology, June 23, 2023 - Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Nature Communications, June 22, 2023 - Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
Nature Communications, June 22, 2023 - Modelling viral encephalitis caused by herpes simplex virus 1 infection in cerebral organoids
Nature Microbiology, June 22, 2023 - Higher convergence of human-great ape enteric eukaryotic viromes in central African forest than in a European zoo: a One Health analysis
Nature Communications, June 21, 2023
May 2023
- Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas
Science Translational Medicine, May 31, 2023 - Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses
Cell reports medicine, May 29 2023 - Toward Comprehensive Care for Long Covid
NEJM, May 9, 2023 - Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Science translational medicine, May 10, 2023
April 2023
- Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies
Vaccine, April 21, 2023 - A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design
JEM, April 14, 2023 - The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Cell, April 13, 2023 - Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection
Communications biology, April 7, 2023
March 2023
- Cytotoxic CD4+ T cells eliminate senescent cells by targeting cytomegalovirus antigen
Cell, March 30, 2023 - SARS-CoV-2 restructures host chromatin architecture
Nature microbiology March 23 2023 - Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
Lancet Infectious Diseases, March 15, 2023 - Advances in developing ACE2 derivatives against SARS-CoV-2
Lancet Microbe, March 16, 2023 - Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
Lancet Infectious Diseases, March 13, 2023 - The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study
Lancet Regional Health, March 13, 2022 - Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates
Nature Communications, March 10, 2023 - Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe
Nature Scientific Reports, March 8, 2023 - Long-term gastrointestinal outcomes of COVID-19
Nature Communications, March 7, 2023 - Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Nature Communications, March 7, 2023 - Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
Cell Reports, March 6, 2023 - Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
Lancet Regional Health, March 6 2023
- Sniffer dogs performance is stable over time in detecting COVID-19 positive samples and agrees with the rapid antigen test in the field
Nature Scientific Reports, March 5, 2023
- Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later
Science Translational Medicine, March 1, 2023
February 2023
- Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022
Nature Cardiovascular Research, February 27, 2023 - SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
Immunity, February 27, 2023 - Relationship between antidepressants and severity of SARS-CoV-2 Omicron infection: a retrospective cohort study using real-world data
Lancet regional health, February 27, 2023 - Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial
JAMA, February 20, 2023 - Transcriptionally active nasopharyngeal commensals and opportunistic microbial dynamics define mild symptoms in the COVID 19 vaccination breakthroughs
PLoS Pathogens, February 17, 2023 - Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Immunity, February 15, 2023 - An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
Science Translational Medicine, February 15, 2023 - Why we need a deeper understanding of the pathophysiology of long COVID
Lancet Infectious Diseases, February 14, 2023 - Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination
J Virol, February 13, 2023 - A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
Cell, February 10, 2023 - Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis
Lancet, February 8, 2023 - Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
Lancet Regional Health, February 5, 2023 - ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
Lancet Infectious Diseases, February 3, 2023 - High-depth sequencing characterization of viral dynamics across tissues in fatal COVID-19 reveals compartmentalized infection
Nature Communications, February 2, 2023 - VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
NEJM, February 2, 2023
January 2023
- Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
Lancet infectious diseases, January 30, 2023 - The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19
Nature immunology, January 30, 2023 - Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
Cell Reports, January 26, 2023 - Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
Cell Reports, January 26, 2023 - Effectiveness of Bivalent Boosters against Severe Omicron Infection
NEJM, January 25, 2023 - Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine
NEJM, January 25, 2023 - Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study
eBioMedicine, January 24, 2023 - Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
Cell Research, January 25, 2023 - Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
ISME Journal, January 23, 2023 - Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Trends in Molecular Medicine, January 22, 2023 - The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials
Lancet Infectious Diseases, January 19, 2023 - Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
NEJM, January 18, 2023 - Protection against Reinfection with the Omicron BA.2.75 Subvariant
NEJM, January 18, 2023 - Molecular fate-mapping of serum antibody responses to repeat immunization
Nature, January 16, 2023 - Long COVID: major findings, mechanisms and recommendations
Nature Reviews Microbiology, January 13, 2023 - Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Nature Communications, January 12, 2023 - Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
Cell Reports, January 11, 2023 - Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
NEJM, January 11, 2023 - Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation
Nature, January 11, 2023 - Innate immune evasion strategies of SARS-CoV-2
Nature Reviews Microbiology, January 11, 2023 - SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19
Nature Communications, January 10, 2023 - SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine
Cell Reports, January 9, 2023 - Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
NEJM, January 5, 2023 - MPXV Transmission at a Tattoo Parlor
NEJM, January 5, 2023 - B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
Nature Communications, January 4, 2023 - Features and risk factors of post-COVID-19 syndrome: Findings from a longitudinal study in Bangladesh
Lancet Regional Health, January 2, 2023 - Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines in US veterans
Nature Microbiology, January 2, 2023 - Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Nature Medicine, January 2, 2023 - Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
Lancet Infectious Diseases, January 2023 - Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
NEJM December 21, 2022 - Rapid emergence of omicron sublineages expressing spike protein R346T
Lancet Regional Health, January 2023
- Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
mBio, November 2, 2020 - The effect of influenza vaccination on trained immunity: impact on COVID-19
Medrxiv, October 16, 2020 - Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil
BMJ, 2020